ONGLYZA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health 107, Llc. The primary component is Saxagliptin Hydrochloride.
Product ID | 55154-6931_048ab1ca-6e74-49ad-9a9e-c866a2b9ce01 |
NDC | 55154-6931 |
Product Type | Human Prescription Drug |
Proprietary Name | ONGLYZA |
Generic Name | Saxagliptin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2014-11-20 |
Marketing Category | NDA / NDA |
Application Number | NDA022350 |
Labeler Name | Cardinal Health 107, LLC |
Substance Name | SAXAGLIPTIN HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2014-11-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022350 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-11-20 |
Marketing Category | NDA |
Application Number | NDA022350 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-11-20 |
Marketing End Date | 2018-02-28 |
Ingredient | Strength |
---|---|
SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 |
SPL SET ID: | e4f2a84f-5117-4738-b769-aba8debbddb0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0310-6100 | ONGLYZA | SAXAGLIPTIN |
0310-6105 | ONGLYZA | SAXAGLIPTIN |
55154-6931 | ONGLYZA | SAXAGLIPTIN |